Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04770402 · ClinicalTrials.gov registry record · NA
Acupuncture for Chemo-Induced Peripheral Neuropathy in Multiple Myeloma Patients
A NA study, sponsored by Wake Forest University Health Sciences.
- Terminated
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT04770402 is a NA study that was terminated before completion, run by Wake Forest University Health Sciences. The registered enrollment target is 12 participants.
The verdict
NCT04770402, a NA study, was terminated before completion, sponsored by Wake Forest University Health Sciences.
- TERMINATED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
This randomized, controlled trial is designed to evaluate the effect of acupuncture on Chemotherapy-Induced Peripheral Neuropathy (CIPN), other symptoms, and potential opioid and concomitant medication sparing effects in comparison to standard of care management in Multiple Myeloma subjects.
Interventions
- OTHER Acupuncture
- OTHER Standard of Care CIPN management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2021-09-15 |
| Est. Completion | 2023-04-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04770402
The ClinicalTrials.gov registry entry for NCT04770402 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Acupuncture is the first listed.
NCT04770402 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04770402 about?
NCT04770402 is a clinical study titled "Acupuncture for Chemo-Induced Peripheral Neuropathy in Multiple Myeloma Patients". This randomized, controlled trial is designed to evaluate the effect of acupuncture on Chemotherapy-Induced Peripheral Neuropathy (CIPN), other symptoms, and potential opioid and concomitant medication sparing effects in comparison to standard of care management in Multiple Myeloma subjects.
What is the current status of trial NCT04770402?
This trial is currently terminated. It is a NA study. The enrollment target is 12 participants. The study started on 2021-09-15. Estimated completion is 2023-04-06.
What interventions are being tested in trial NCT04770402?
The interventions under investigation include: Acupuncture (OTHER), Standard of Care CIPN management (OTHER).
Who is sponsoring clinical trial NCT04770402?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.